Technical Analysis for PTN - Palatin Technologies, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Down |
| See historical PTN trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| 200 DMA Resistance | Bearish | 0.18% | |
| Fell Below 20 DMA | Bearish | 0.18% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.18% | |
| NR7 | Range Contraction | 0.18% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/12/2019
- Sector: Healthcare
- Industry: Diagnostics & Research
Palatin Technologies, Inc., a biopharmaceutical company, engages in the development of peptide therapeutics for the treatment of diseases. Its drug development programs include Bremelanotide, a peptide melanocortin receptor agonist that is in Phase IIb clinical trials for the treatment of female sexual dysfunction; and PL-3994, a peptide mimetic natriuretic peptide receptor A agonist, which is in Phase I clinical trials for the treatment of cardiovascular and pulmonary indications, as well as melanocortin receptor-based compounds for treatment of obesity. The company was founded in 1986 and is based in Cranbury, New Jersey.
Chemistry Biopharmaceutical Diseases Molecular Biology Obesity Endocrine System Drug Development Peptides Treatment Of Obesity Female Sexual Dysfunction Therapeutics For The Treatment Of Diseases
Chemistry Biopharmaceutical Diseases Molecular Biology Obesity Endocrine System Drug Development Peptides Treatment Of Obesity Female Sexual Dysfunction Therapeutics For The Treatment Of Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more PTN news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 1.78 |
| 52 Week Low | 0.1 |
| Average Volume | 1,387,352 |
| 200-Day Moving Average | 0.9848 |
| 50-Day Moving Average | 0.9158 |
| 20-Day Moving Average | 0.9442 |
| 10-Day Moving Average | 0.9954 |
| Average True Range | 0.0597 |
| ADX | 23.09 |
| +DI | 22.379 |
| -DI | 22.1518 |
| Chandelier Exit (Long, 3 ATRs ) | 0.9539 |
| Chandelier Exit (Short, 3 ATRs ) | 1.0491 |
| Upper Bollinger Band | 1.0636 |
| Lower Bollinger Band | 0.8248 |
| Percent B (%b) | 0.48 |
| BandWidth | 25.291252 |
| MACD Line | 0.0155 |
| MACD Signal Line | 0.0161 |
| MACD Histogram | -0.0007 |
| Fundamentals | Value |
|---|---|
| Market Cap | 168.12 Million |
| Num Shares | 179 Million |
| EPS | -0.08 |
| Price-to-Earnings (P/E) Ratio | -11.74 |
| Price-to-Sales | 3.03 |
| Price-to-Book | 0.00 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.00 | ||||
| Resistance 3 (R3) | 1.01 | 0.99 | 0.99 | ||
| Resistance 2 (R2) | 0.99 | 0.98 | 0.99 | 0.99 | |
| Resistance 1 (R1) | 0.97 | 0.97 | 0.98 | 0.96 | 0.98 |
| Pivot Point | 0.95 | 0.95 | 0.96 | 0.95 | 0.95 |
| Support 1 (S1) | 0.92 | 0.93 | 0.94 | 0.92 | 0.89 |
| Support 2 (S2) | 0.91 | 0.92 | 0.91 | 0.89 | |
| Support 3 (S3) | 0.88 | 0.91 | 0.89 | ||
| Support 4 (S4) | 0.88 |
